Penetration of ofloxacin into human lung tissue following a single oral dose of 200 milligrams. 1991

F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
Department of Thoracic Surgery, Sheba Medical Center, Tel Hashomer, Israel.

The penetration of ofloxacin into lung tissue was studied in 10 patients subjected to pulmonary surgery. Samples of blood and lung tissue were obtained 3 to 8 h (mean, 5 h) after oral administration of 200 mg. The mean level in tissue was 2.17 +/- 0.5 micrograms/g, while the mean level in serum was 0.85 +/- 0.23 micrograms/ml. The mean lung tissue/serum concentration ratio was 2.55 +/- 0.30. The achievable levels of ofloxacin in lung tissue are above the MICs for most pulmonary pathogens.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
January 1987, Chemotherapy,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
September 1988, The Journal of antimicrobial chemotherapy,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
November 2006, The Journal of antimicrobial chemotherapy,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
April 2001, The Journal of antimicrobial chemotherapy,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
January 2003, Polish journal of pharmacology,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
September 1990, The Journal of urology,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
January 1987, Drugs,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
January 1986, Infection,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
January 1989, Chemotherapy,
F Serour, and M Dan, and A Gorea, and A Yellin, and Y Lieberman, and S A Berger
November 1996, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!